Cargando…
Patent and Exclusivity Status of Essential Medicines for Non-Communicable Disease
OBJECTIVE: The threat of non-communicable diseases (“NCDs”) is increasingly becoming a global health crisis and are pervasive in high, middle, and low-income populations resulting in an estimated 36 million deaths per year. There is a need to assess intellectual property rights (“IPRs”) that may imp...
Autores principales: | Mackey, Tim K., Liang, Bryan A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3511406/ https://www.ncbi.nlm.nih.gov/pubmed/23226453 http://dx.doi.org/10.1371/journal.pone.0051022 |
Ejemplares similares
-
Patent and Marketing Exclusivities 101 for Drug Developers
por: Oronsky, Bryan, et al.
Publicado: (2023) -
Selection of WHO-recommended essential medicines for non-communicable diseases on National Essential Medicines Lists
por: Jarvis, Jordan D., et al.
Publicado: (2019) -
Patent pooling to increase access to essential medicines
por: Burrone, Esteban, et al.
Publicado: (2019) -
In which developing countries are patents on essential medicines being filed?
por: Beall, Reed F, et al.
Publicado: (2017) -
Patent Medicine
por: Craig, A. L.
Publicado: (1883)